Venture Capital

BioSystem Development, a Middleton biotech firm that has developed a new system for protein analysis, will receive more than $700,000 in equity funding from two Wisconsin angel investment groups....

Third Wave Technologies has applied for Food and Drug Administration approval of a new molecular test to detect Cystic Fibrosis, a hereditary disease that affects 30,000 Americans. The company filed a 510(k), a type of application that helps companies get their products on the U.S....

Pharma stocks had a mixed performance in 2006, and merger and acquisition activity was the name of the game for the likes of Abbott Labs, 3M, and Monsanto, according to columnist Michael Rosen. In this edition of Yer Biotech Blues, he predicts the M&A trend...

Wisconsin made moderate progress as a “Knowledge Economy” state in 2006, according to Inside Wisconsin columnist Tom Still, but the state has plenty of hard work ahead on investment, biofuel development, and IT labor needs. Instead of free tuition for college grads that promise to...

In the view of venture investors and others in the technology community, Wisconsin Act 255, the law designed to spur greater venture investment in Wisconsin companies, is a good model with significant room for improvement. The Wisconsin Technology Council has made recommendations designed to...

CellCura, a Norwegian biotechnology company, has opened an office in Madison to facilitate collaboration with scientists at the WiCell Research Institute, and that has visions of a stem cell invasion dancing in the heads of Wisconisn biotechnology officials. CellCura will open in Madison's University Research...

Bringing entrepreneurship to economically disadvantaged areas is one of the goals of an entrepreneurship initiative established by the Kauffman Foundation, and the University of Wisconsin-Madison is one of eight campuses selected to participate in the program. To help make it happen, the university has received...

Addressing the problem of antibiotic resistance has helped Madison-based ConjuGon land $3.3 million in capital from Rosetta Partners and Wisconsin Investment Partners. ConjuGon will use the money not only to develop its core antibacterial technology, but to prepare for clinical trials of its treatment for...

Mark Ramirez, a former Sonic Foundry software engineer, is quietly building a technology company that specializes in voice-changing software, and he's getting a little help from his friends. Ramirez, CEO of Screaming Bee, LLC, is delighted that customers are willing to shape his software products. ...

With the goal of connecting institutional investors to Wisconsin companies, the State Department of Financial Institutions and the Department of Commerce are collaborating on a proposal to create a Wisconsin Venture Center. The center is based on an Ohio collaborative model called BioEnterprise....